V Convención Científica Internacional UCLV 2025
  • Home
  • Events
  • Memorias
    • CCI 2021
    • Memorias CCI 2023
  • Sponsorships
  • 0
  • Sign in
English (US) Español
Back
  • Symposium

Executive Secretary

VIII Symposium "Design, Obtaining and Development of Drugs" "SICF"

VIII International Symposium on Chemistry and Pharmaceutical Sciences

SICF

VIII Symposium "Design, Obtaining and Development of Drugs"

  • Introduction
  • Papers
  • Submit a paper
  • Agenda
  • Community
characterization ×

Book your talks

Plan your experience by adding your favorites talks to your wishlist

  • Tuesday 14
    November 2023

    Physicochemical Characterization of a new anti-PD1 Monoclonal Antibody biosimilar candidate of nivolumab obtained in CHO-K1 cell line.
    Roberto Machado Santisteban
    anticuerpo monoclonal biosimilar caracterización characterization monoclonal antibody
    Characterization of the RBD-hFc fusion protein used in diagnostics for COVID-19 UMELISA SARS-CoV-2-IgG
    Ingrid Ruiz
    analytical techniques caracterización characterization fusion protein protein proteína proteína de fusión rbd-hfc técnicas analíticas


Instituto Finlay de Vaunas Gold
EAA Heriberto Duquesne Gold
Álamo Empresa Cárnica Silver
BIOCUBAFARMA Silver
Centro de Análisis del Ciclo de Vida (CADIS) Bronze

Designed
for Companies

We are a team of passionate people whose goal is to improve everyone's life.
Our services are designed for small to medium size companies.

  • Home
  • Contact us
  • +1 (650) 691-3277
  • info@yourcompany.example.com
Share
Copyright © SICTE S.A. - DESOFT V Convención Científica Internacional UCLV 2025
English (US) Español
Powered by Odoo Developed by Desoft